Expand NVCR Menu
NVCR MENU

NVCR Latest Press Releases

-- September 2, 2026 --

Novocure Announces Upcoming Investor Events Business Wire 7:00 AM

-- July 23, 2026 --

Novocure Reports Second Quarter 2026 Financial Results Business Wire 7:00 AM

-- July 14, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR Globe Newswire 6:24 PM

-- July 9, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR PRNewswire 5:41 PM

-- July 7, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR Globe Newswire 5:57 PM

-- July 1, 2026 --

Novocure to Report Second Quarter 2026 Financial Results Business Wire 7:00 AM

-- June 30, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR Globe Newswire 5:16 PM
Novocure's Optune Pax Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer Business Wire 7:00 AM

-- June 25, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR PRNewswire 7:36 PM

-- June 20, 2026 --

NVCR Investors Have Opportunity to Join NovoCure Limited Fraud Investigation with the Schall Law Firm Business Wire 1:34 PM

-- June 18, 2026 --

Novocure Limited Investigation Initiated: SueWallSt Investigates the Officers and Directors of Novocure Limited (NVCR) PRNewswire 9:41 PM
Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma Business Wire 7:00 AM

-- April 30, 2026 --

Novocure Reports First Quarter 2026 Financial Results Business Wire 7:00 AM
Market Data Delayed 15 Minutes